Where does Sequana Medical NV rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Sequana Medical NV ranks #11,797 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Sequana Medical NV hold?

Sequana Medical NV holds 26 US utility patents granted between 2015 and 2023, spanning 10 technology areas.

What is Sequana Medical NV's Innovation Score?

Sequana Medical NV has an Innovation Score of 41.5 out of 100 (top 33% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Sequana Medical NV's patent grant rate increasing or decreasing?

Sequana Medical NV's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Sequana Medical NV's patents?

Sequana Medical NV's patents average 18.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Sequana Medical NV patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sequana Medical NV

Q: What technology areas does Sequana Medical NV focus on?

Sequana Medical NV's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 24 patents, ranking #299 of 3,490 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 26 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Sequana ranks #11,797 of 49,997 tracked US assignees by granted-patent volume, with 26 patents across 10 technology areas.

#11,797
of 49,997 US assignees by volume: Top 33%
by Innovation Score (41.5/100): 18.9
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11797 · Foreign Corporation #11,797 · 26 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-FLAT · BOOK-FULL

GRANTS-SMALL 26 grants
UPPER-Q #11,797/49,997
PHOTO-FINISH Samsung Electro-Meha…
CPC-FOCUS A61M · 10 areas
INNOV-PAR 41.5/100
CLAIMS-RICH 18.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Samsung Electro-Mehanics Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Sequana’s 41.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.4 pts (27%) Velocity 7.6 pts (18%) Breadth 11.2 pts (27%) Claim depth 11.3 pts (27%)

Qualcomm Incorporated · highest

85
Syncrude Canada in… · near

42
Aragon Pharmaceuticals · near

42
Cianna Medical · near

42
Sequana Medical · this assignee

42
Welspun India · near

42
3D Lighting… · lowest

7

What this shows Sequana's Innovation Score is 41.5/100 (top 33% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Sequana?

Each dot is one of Sequana’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Sequana’s own 18.9 claims/patent is ABOVE the 8.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Sequana vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Sequana's grants concentrate

Sequana Medical NV is a focused PatentsView assignee: 10 CPC subclasses with 92.3% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2015 (6 grants) versus a trough of 1 in 2016. By volume, Sequana sits between Samsung Electro-Mehanics Co., Ltd. and Shock Therapy Suspension, Inc..

Sequana's three-year grant acceleration

Sequana Medical NV shows 8 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Samsung Electro-m…

26
San Diego State U…

26
Sandvik Mining an…

26
Senic

26
Shanghai Ocean Un…

26
Shanxi University

26
Shenzhen Leshuo T…

26
Shock Therapy Sus…

26
Sequana Medical ◀

26

What this shows Sequana holds 26 patents at rank #11,812, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sequana

By rank, the assignees closest to #11,812 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Sequana's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Sequana, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Sequana ranks #299 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Cianna Medical, Inc. 42 Welspun India Limited 42 Aragon Pharmaceuticals, Inc. 42 Syncrude Canada Ltd. in trust for the owners of the Syncrude Project as such owners exist now and in the future 42

Sequana's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 33% higher than 67% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sequana Medical NV patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	6	23.1%
2016	1	3.8%
2017	2	7.7%
2018	2	7.7%
2019	2	7.7%
2020	3	11.5%
2021	2	7.7%
2022	2	7.7%
2023	6	23.1%

Which technologies does Sequana Medical NV patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 24

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 6

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 6

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 6

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 6

A61B - DIAGNOSIS; SURGERY; Identification 3

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 2

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

H02J - Circuit Arrangements OR Systems FOR Supplying OR Distributing Electric POWER; Systems FOR Storing Electric Energy 1

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Sequana Medical NV's patent record in context - here's where to go next.

Sequana Medical NV's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 92.3% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,797 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Sequana Medical NV against Samsung Electro-Mehanics Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 41.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.